FDA fully approves the Pfizer COVID‑19 vaccine

On August 23, 2021, the Food and Drug Administration (FDA) fully approves the Pfizer-BioNTech COVID-19 vaccine for people aged 16 and older, following a manufacturing review and analysis of the company’s expanded clinical trial, which included approximately 44,000 participants and found the vaccine to be 91 percent effective in preventing COVID-19.
View More →